SON.HO.UN.ADR 1/5 SF -05 - Asset Resilience Ratio
SON.HO.UN.ADR 1/5 SF -05 (PHBA) has an Asset Resilience Ratio of 0.19% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore total assets of SON.HO.UN.ADR 1/5 SF -05 for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how SON.HO.UN.ADR 1/5 SF -05's Asset Resilience Ratio has changed over time. See debt-free asset ratio of SON.HO.UN.ADR 1/5 SF -05 to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down SON.HO.UN.ADR 1/5 SF -05's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PHBA market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €10.50 Million | 0.19% |
| Total Liquid Assets | €10.50 Million | 0.19% |
Asset Resilience Insights
- Limited Liquidity: SON.HO.UN.ADR 1/5 SF -05 maintains only 0.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SON.HO.UN.ADR 1/5 SF -05 Industry Peers by Asset Resilience Ratio
Compare SON.HO.UN.ADR 1/5 SF -05's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
Xvivo Perfusion AB
ST:XVIVO |
Medical Devices | 12.30% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
PetVivo Holdings Inc
NASDAQ:PETV |
Medical Devices | 2.18% |
Annual Asset Resilience Ratio for SON.HO.UN.ADR 1/5 SF -05 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for SON.HO.UN.ADR 1/5 SF -05.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.00% | €200.00K ≈ $233.82K |
€5.92 Billion ≈ $6.93 Billion |
0.00pp |
| 2024-03-31 | 0.00% | €200.00K ≈ $233.82K |
€5.79 Billion ≈ $6.77 Billion |
0.00pp |
| 2023-03-31 | 0.00% | €200.00K ≈ $233.82K |
€5.55 Billion ≈ $6.49 Billion |
+0.00pp |
| 2022-03-31 | 0.00% | €200.00K ≈ $233.82K |
€5.59 Billion ≈ $6.53 Billion |
-- |
About SON.HO.UN.ADR 1/5 SF -05
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hea… Read more